VSEE HEALTH, INC. (VSEE) Form 8-K — Jun 5, 2026
VSee Health, Inc. has completed the sale of its wholly-owned subsidiary, VSee Lab, Inc., to Milton Chen, the company’s former co-CEO and Chairman. The transaction closed on May 31, 2026, under a Stock Purchase Agreement wherein Chen acquired all equity securities of VSee Lab in exchange for transferring his entire holding of 2,870,069 shares of VSee Health common stock to the company. Concurrent with the sale, Milton Chen resigned as co-CEO and Chairman of VSee Health.
Key figures
- Shares Repurchased
- 2870069
- Pro Forma Revenue FY 2025
- 7302954
- Pro Forma Revenue Q1 2026
- 1879293
- Closing Date
- 2026-05-31
- Transaction Type
- Sale of subsidiary VSee Lab to Milton Chen
- Consideration Type
- Transfer of 2,870,069 shares of VSee Health Common Stock owned by Chen
Price after filing
Close on the filing date to close N calendar days later (from $0.17). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.